| [1] |
Arnold M, Sierra MS, Laversanne M, et al. Global patterns and trends in colorectal cancer incidence and mortality[J]. Gut, 2017, 66(4) : 683-691.
|
| [2] |
van der Valk MJM, Hilling DE, Bastiaannet E, et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study[J]. Lancet, 2018, 391 (10139) : 2537-2545.
|
| [3] |
Al-Sukhni E, Attwood K, Mattson DM, et al. Predictors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer[J]. Ann Surg Oncol, 2016, 23(4) : 1177-1186.
|
| [4] |
Hammarstrom S. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues[J]. Semin Cancer Biol, 1999, 9(2) : 67-81.
|
| [5] |
Gold P, Freedman SO. Specific carcinoembryonic antigens of the human digestive system[J]. J Exp Med, 1965, 122(3) : 467-481.
|
| [6] |
Boonstra MC, de Geus SWL, Prevoo HAJM, et al. Selecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane Proteins[J]. Biomark Cancer, 2016, 8 : 119-133.
|
| [7] |
陈保祥，江从庆，钱群. 吲哚菁绿荧光造影在结直肠外科手术中的应用进展[J/CD]. 中华普外科手术学杂志(电子版)，2020，14(1)：101-105.
|
| [8] |
Metildi CA, Kaushal S, Pu M, et al. Fluorescence-guided surgery with a fluorophore-conjugated antibody to carcinoembryonic antigen (CEA), that highlights the tumor, improves surgical resection and increases survival in orthotopic mouse models of human pancreatic cancer[J]. Ann Surg Oncol, 2014, 21(4) : 1405-1411.
|
| [9] |
Gutowski M, Framery B, Boonstra MC, et al. SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery[J]. Surg Oncol, 2017, 26(2) : 153-162.
|
| [10] |
Meijer RPJ, de Valk KS, Deken MM, et al. Intraoperative detection of colorectal and pancreatic liver metastases using SGM-101, a fluorescent antibody targeting CEA[J]. Eur J Surg Oncol, 2021, 43(3 Pt B) : 667-673.
|
| [11] |
Clarke P, Mann J, Simpson JF, et al. Mice transgenic for human carcinoembryonic antigen as a model for immunotherapy[J]. Cancer Res, 1998, 58(7) : 1469-1477.
|
| [12] |
Framery B, Gutowski M, Dumas K, et al. Toxicity and pharmacokinetic profile of SGM-101, a fluorescent anti-CEA chimeric antibody for fluorescence imaging of tumors in patients[J]. Toxicol Rep, 2019, 6 : 409-415.
|
| [13] |
Urano Y, Sakabe M, Kosaka N, et al. Rapid cancer detection by topically spraying a γ-glutamyltranspeptidase-activated fluorescent probe[J]. Sci Transl Med, 2011, 3(110) : 110ra119.
|
| [14] |
Nguyen QT, Tsien RY. Fluorescence-guided surgery with live molecular navigation--a new cutting edge[J]. Nat Rev Cancer, 2013, 13(9) : 653-662.
|
| [15] |
Boogerd LSF, Hoogstins CES, Schaap DP, et al. Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study[J]. Lancet Gastroenterol Hepatol, 2018, 3(3) : 181-191.
|
| [16] |
de Valk KS, Deken MM, Schaap DP, et al. Dose-Finding Study of a CEA-Targeting Agent, SGM-101, for Intraoperative Fluorescence Imaging of Colorectal Cancer[J]. Ann Surg Oncol, 2020, 28(4) : 1-13.
|
| [17] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6) : 394-424.
|
| [18] |
Bhandare M, Patil P, Pai V, et al. Peritoneal Carcinomatosis in Colorectal Cancers-Management Perspective Needs a Change[J]. Clin Colorectal Cancer, 2017, 16(2) : e1-e6.
|
| [19] |
Stewart CL, Warner S, Ito K, et al. Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure？[J]. Curr Probl Surg, 2018, 55(9) : 330-379.
|
| [20] |
Sugarbaker PH. Peritonectomy procedures[J]. Surg Oncol Clin N Am, 2003, 12(3) : 703-727，xiii.
|
| [21] |
Ihemelandu C, Sugarbaker PH. Management for Peritoneal Metastasis of Colonic Origin: Role of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: A Single Institution’s Experience During Two Decades[J]. Ann Surg Oncol, 2017, 24(4) : 898-905.
|
| [22] |
Metildi CA, Kaushal S, Luiken GA, et al. Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model[J]. J Surg Oncol, 2014, 109(5) : 451-458.
|
| [23] |
Schaap DP, de Valk KS, Deken MM, et al. Carcinoembryonic antigen-specific, fluorescent image-guided cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer[J]. Br J Surg, 2020, 107(4) : 334-337.
|
| [24] |
Dwyer RH, Scheidt MJ, Marshall JS, et al. Safety and efficacy of synchronous robotic surgery for colorectal cancer with liver metastases[J]. J Robot Surg, 2018, 12(4) : 603-606.
|
| [25] |
Adam R, Kitano Y. Multidisciplinary approach of liver metastases from colorectal cancer[J]. Ann Gastroenterol Surg, 2019, 3(1) : 50-56.
|
| [26] |
Montalti R, Tomassini F, Laurent S, et al. Impact of surgical margins on overall and recurrence-free survival in parenchymal-sparing laparoscopic liver resections of colorectal metastases[J]. Surg Endosc, 2015, 29(9) : 2736-2747.
|
| [27] |
Al Bandar MH, Kim NK. Current status and future perspectives on treatment of liver metastasis in colorectal cancer[J]. Oncol Rep, 2017, 37(5) : 2553-2564.
|
| [28] |
Handgraaf HJM, Boogerd LSF, Hoppener DJ, et al. Long-term follow-up after near-infrared fluorescence-guided resection of colorectal liver metastases: A retrospective multicenter analysis[J]. Eur J Surg Oncol, 2017, 43(8) : 1463-1471.
|
| [29] |
Boogerd LS, Handgraaf HJ, Lam HD, et al. Laparoscopic detection and resection of occult liver tumors of multiple cancer types using real-time near-infrared fluorescence guidance[J]. Surg Endosc, 2017, 31(2) : 952-961.
|
| [30] |
Hiroshima Y, Lwin TM, Murakami T, et al. Effective fluorescence-guided surgery of liver metastasis using a fluorescent anti-CEA antibody[J]. J Surg Oncol, 2016, 114(8) : 951-958.
|
| [31] |
Hollandsworth HM, Nishino H, Turner M, et al. Humanized Fluorescent Tumor-associated Glycoprotein-72 Antibody Selectively Labels Colon-cancer Liver Metastases in Orthotopic Mouse Models[J]. In Vivo, 2020, 34(5) : 2303-2307.
|
| [32] |
Bodet-Milin C, Bailly C, Touchefeu Y, et al. Clinical Results in Medullary Thyroid Carcinoma Suggest High Potential of Pretargeted Immuno-PET for Tumor Imaging and Theranostic Approaches[J]. Front Med (Lausanne), 2019, 6 : 124.
|